Literature DB >> 15339697

An inv(16)(p13q22) positive acute myeloid leukaemia relapsing as acute precursor B-cell lymphoblastic leukaemia.

Nancy Boeckx1, Vincent H J van der Velden, Marc Boogaerts, Anne Hagemeijer, Peter Vandenberghe, Jacques J M van Dongen.   

Abstract

We describe a case of a 38-year old male with inv(16)(p13q22) positive acute myeloid leukaemia (AML) with eosinophilia, relapsing after a molecular remission of almost three years. Remarkably, the leukaemia at relapse was identified as a precursor-B-cell acute lymphoblastic leukaemia (B-ALL) by cytology and immunophenotyping, but was inv(16)(p13q22) positive as revealed by interphase FISH, FICTION analysis, and real-time quantitative PCR. Analysis of immunoglobulin and T-cell receptor genes showed a bi-allelic DH2-JH rearrangement at relapse, but not at diagnosis. These findings indicate a myeloid to lymphoid lineage switch from an inv(16)(p13q22) positive leukaemia and show that IGH gene rearrangements can occur in the presence of CBFB-MYH11 fusion transcripts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15339697

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  6 in total

1.  Pbx1 restrains myeloid maturation while preserving lymphoid potential in hematopoietic progenitors.

Authors:  Francesca Ficara; Laura Crisafulli; Chenwei Lin; Masayuki Iwasaki; Kevin S Smith; Luca Zammataro; Michael L Cleary
Journal:  J Cell Sci       Date:  2013-05-09       Impact factor: 5.285

2.  Cbfbeta-SMMHC impairs differentiation of common lymphoid progenitors and reveals an essential role for RUNX in early B-cell development.

Authors:  Ya-Huei Kuo; Rachel M Gerstein; Lucio H Castilla
Journal:  Blood       Date:  2007-10-16       Impact factor: 22.113

3.  Lineage switch from precursor B cell acute lymphoblastic leukemia to acute monocytic leukemia at relapse.

Authors:  Osamu Imataki; Hiroaki Ohnishi; Genji Yamaoka; Takeshi Arai; Akira Kitanaka; Yoshitsugu Kubota; Yoshio Kushida; Toshihiko Ishida; Terukazu Tanaka
Journal:  Int J Clin Oncol       Date:  2010-02       Impact factor: 3.402

4.  Erythroleukemia relapsing as precursor B-cell lymphoblastic leukemia.

Authors:  Borae G Park; Chan-Jeoung Park; Seongsoo Jang; Eul Ju Seo; Hyun-Sook Chi; Jung-Hee Lee
Journal:  Korean J Lab Med       Date:  2011-04

5.  Tracing dynamics and clonal heterogeneity of Cbx7-induced leukemic stem cells by cellular barcoding.

Authors:  Karin Klauke; Mathilde J C Broekhuis; Ellen Weersing; Albertina Dethmers-Ausema; Martha Ritsema; Marta Vilà González; Erik Zwart; Leonid V Bystrykh; Gerald de Haan
Journal:  Stem Cell Reports       Date:  2014-11-26       Impact factor: 7.765

6.  CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity.

Authors:  Elad Jacoby; Sang M Nguyen; Thomas J Fountaine; Kathryn Welp; Berkley Gryder; Haiying Qin; Yinmeng Yang; Christopher D Chien; Alix E Seif; Haiyan Lei; Young K Song; Javed Khan; Daniel W Lee; Crystal L Mackall; Rebecca A Gardner; Michael C Jensen; Jack F Shern; Terry J Fry
Journal:  Nat Commun       Date:  2016-07-27       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.